WAIS IV
Diagnostic TestPsychological assessement
NCT Number: NCT06489912
Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes.
Interested in participating?
Request Info12 year–16 year
All sexes
Observational
CHU Bourgogne Franche Comté, Besançon, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Psychological assessement
Time frame: Inclusion
assessed according to DSM-5 by K- SADS-PL
Time frame: Inclusion
assessed according to DSM-5 by K- SADS-PL
Time frame: Inclusion
Traumatisms
Time frame: Inclusion
Attachement
Time frame: Inclusion
Toronto Alexithymia Scale
Time frame: Inclusion
Empathy scale
Time frame: Inclusion
Impulsivity scale
Time frame: Inclusion
Reflective self esteem scale
Time frame: Inclusion
Abbreviated-diagnostic interview for borderlines
Time frame: Inclusion
Hostility
Time frame: Inclusion
Buss Durkee Hostility Inventory
Time frame: Inclusion
Mentoring assessed by Reflective Functioning Questionnaire
Time frame: Inclusion
Coping strategies assessed by Adolescent Coping Scale
Time frame: Inclusion
Risk behaviour assessed by COLUMBIA-SUICIDE SEVERITY RATING SCALE
Time frame: Inclusion
Raven's Matrix
Time frame: Inclusion
Adverse Child Experiences
Contact information is provided by the study sponsor or research team.
University Hospital, Rouen
Other
Etat Des Lieux de la santé Mentale Des Adolescents Suivis Par Les Dispositifs ITEP en France
Acronym: PsyPreDi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05138614
Behavior, Chemically-Induced Disorders
Holyoke, Massachusetts, United States
View Trial DetailsNCT05700474
Behavior, Chemically-Induced Disorders
Charlotte, North Carolina, United States
View Trial DetailsNCT05920252
Anhedonia, Behavior
New York, United States
View Trial DetailsNCT07299526
Mental Disorders, Mental Health Disorder
Strasbourg, France
View Trial Details